Cocrystal Pharma, Inc. (NASDAQ:COCP – Get Rating) saw a significant decrease in short interest in May. As of May 15th, there was short interest totalling 58,200 shares, a decrease of 58.4% from the April 30th total of 139,900 shares. Approximately 0.1% of the company’s shares are short sold. Based on an average trading volume of 279,000 shares, the days-to-cover ratio is presently 0.2 days.
Shares of NASDAQ:COCP traded up $0.02 during mid-day trading on Friday, reaching $0.42. 355,783 shares of the stock were exchanged, compared to its average volume of 363,482. The company has a market cap of $40.45 million, a P/E ratio of -2.59 and a beta of 1.13. Cocrystal Pharma has a one year low of $0.37 and a one year high of $1.49. The stock’s 50 day simple moving average is $0.49 and its 200-day simple moving average is $0.59.
Cocrystal Pharma (NASDAQ:COCP – Get Rating) last posted its quarterly earnings data on Wednesday, May 11th. The company reported ($0.04) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.04). As a group, research analysts forecast that Cocrystal Pharma will post -0.16 EPS for the current fiscal year.
COCP has been the subject of several recent analyst reports. HC Wainwright restated a “buy” rating and issued a $4.00 price target on shares of Cocrystal Pharma in a report on Monday, March 14th. Noble Financial restated a “buy” rating and issued a $5.00 price target on shares of Cocrystal Pharma in a report on Thursday, May 12th.
About Cocrystal Pharma (Get Rating)
Cocrystal Pharma, Inc, a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections.
- Get a free copy of the StockNews.com research report on Cocrystal Pharma (COCP)
- Short Sellers Provide Entry Into Hibbet, Inc At Rock Bottom Prices
- Affirm Stock Has Affirmed a Bottom
- Airbnb: Bold Competitive Threats & A New World of Travel
- Is RBC Bearings Rolling Into A Reversal?
- Should Dollar General or Dollar Tree Give Investors a Case of FOMO?
Receive News & Ratings for Cocrystal Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cocrystal Pharma and related companies with MarketBeat.com's FREE daily email newsletter.